July 6, 2014 | The Israeli creator of a hospital bed monitoring device EarlySense received U.S. Food & Drug Administration approval for its monitoring chair. FDA approval will allow the company to market the device to hospitals throughout the United States. EarlySense is an Israeli company with offices in Israel and the U.S. that markets sensors for hospital beds, especially those to help patients connected to many monitoring devices. The sensor is placed under the hospital bed mattress and works by sensing changes in pressure caused by the patient moving in the bed, alerting hospital staff of sudden movements or changes, like when a patient falls out of bed.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Water Management Pioneer Unveils Unique New Anti-Leak Platform
October 06, 2024
Israel Sending 20 Green Tech Firms To UN Climate Conference
October 06, 2024
Tel Aviv University Ranked 7th In World For Global Entrepreneurship
October 01, 2024
Facebook comments